All In Biotech

Investigational drug · Phase 2

TNG462

Not approved by FDA. In 3 industry-sponsored Phase 2 or 3 trials that are active or finished in the last two years, most often for MTAP-deleted Solid Tumors, Locally Advanced Solid Tumor, PDAC.

Phase 2

Last checked: Nov 19, 2026Latest source record: Oct 23, 2026 (newest trial update)Source: ClinicalTrials.govMethods & limitations

Highest phase

Phase 2

Industry-sponsored trials

Phase 2 and 3 trials

3

3 still active

All registered trials

5

Any phase or sponsor naming "TNG462"

First trial start

2023

May 26, 2023

Sponsors

Lead sponsors of its Phase 2 and 3 trials.

All registered trials by phase

Every ClinicalTrials.gov drug study naming "TNG462", any sponsor or status.

Conditions studied

As listed on its trial records.

  • MTAP-deleted Solid Tumors
  • Locally Advanced Solid Tumor
  • PDAC
  • PDAC - Pancreatic Ductal Adenocarcinoma
  • NSCLC
  • RAS Mutation
  • MTAP Deletion
  • Lung Cancer
  • Pancreatic Cancer Metastatic
  • Thoracic Cancer

Approved drugs for the same conditions: Non-small cell lung cancer · Pancreatic cancer · Oncology · Gastroenterology and liver

Largest trials

Live from ClinicalTrials.gov: studies naming "TNG462" as an intervention, largest first.

All trials

Newest research

PubMed records naming it or its code names, newest first.

All 2 on PubMed

Also in development for MTAP-deleted Solid Tumors

  • BAY 3713372Phase 21 trial

    Bayer · MTAP-deleted Solid Tumors

  • S095035Phase 21 trial

    Servier Bio-Innovation LLC · MTAP-deleted Solid Tumors

Names are merged from how sponsors list this drug on ClinicalTrials.gov, so an alias can occasionally belong to a related compound. Development status changes faster than registry records do.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.